Advanced search
1 file | 2.12 MB Add to list

Diagnosis and treatment of male infertility-related fertilization failure

Author
Organization
Abstract
Infertility affects approximately 15% of reproductive-aged couples worldwide, of which up to 30% of the cases are caused by male factors alone. The origin of male infertility is mostly attributed to sperm abnormalities, of which many are caused by genetic defects. The development of intracytoplasmic sperm injection (ICSI) has helped to circumvent most male infertility conditions. However, there is still a challenging group of infertile males whose sperm, although having normal sperm parameters, are unable to activate the oocyte, even after ICSI treatment. While ICSI generally allows fertilization rates of 70 to 80%, total fertilization failure (FF) still occurs in 1 to 3% of ICSI cycles. Phospholipase C zeta (PLC zeta) has been demonstrated to be a critical sperm oocyte activating factor (SOAF) and the absence, reduced, or altered forms of PLC zeta have been shown to cause male infertility-related FF. The purpose of this review is to (i) summarize the current knowledge on PLC zeta as the critical sperm factor for successful fertilization, as well as to discuss the existence of alternative sperm-induced oocyte activation mechanisms, (ii) describe the diagnostic tests available to determine the cause of FF, and (iii) summarize the beneficial effect of assisted oocyte activation (AOA) to overcome FF.
Keywords
male infertility, fertilization failure, ICSI, oocyte activation deficiencies, phospholipase C zeta (PLC&#950, ), PLCZ1 mutations, MOAT, MOCA, HOCA, AOA, PHOSPHOLIPASE-C-ZETA, INTRACYTOPLASMIC SPERM INJECTION, ASSISTED OOCYTE ACTIVATION, DOMAIN-BINDING-PROTEIN, INDUCED CA2+ OSCILLATIONS, PLC-ZETA, ARTIFICIAL OOCYTE, CALCIUM-IONOPHORE, EGG-ACTIVATION, MOUSE EGGS

Downloads

  • jcm-09-03899-v2.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 2.12 MB

Citation

Please use this url to cite or link to this publication:

MLA
Cardona Barberán, Arantxa, et al. “Diagnosis and Treatment of Male Infertility-Related Fertilization Failure.” JOURNAL OF CLINICAL MEDICINE, vol. 9, no. 12, 2020, doi:10.3390/jcm9123899.
APA
Cardona Barberán, A., Boel, A., Vanden Meerschaut, F., Stoop, D., & Heindryckx, B. (2020). Diagnosis and treatment of male infertility-related fertilization failure. JOURNAL OF CLINICAL MEDICINE, 9(12). https://doi.org/10.3390/jcm9123899
Chicago author-date
Cardona Barberán, Arantxa, Annekatrien Boel, Frauke Vanden Meerschaut, Dominic Stoop, and Björn Heindryckx. 2020. “Diagnosis and Treatment of Male Infertility-Related Fertilization Failure.” JOURNAL OF CLINICAL MEDICINE 9 (12). https://doi.org/10.3390/jcm9123899.
Chicago author-date (all authors)
Cardona Barberán, Arantxa, Annekatrien Boel, Frauke Vanden Meerschaut, Dominic Stoop, and Björn Heindryckx. 2020. “Diagnosis and Treatment of Male Infertility-Related Fertilization Failure.” JOURNAL OF CLINICAL MEDICINE 9 (12). doi:10.3390/jcm9123899.
Vancouver
1.
Cardona Barberán A, Boel A, Vanden Meerschaut F, Stoop D, Heindryckx B. Diagnosis and treatment of male infertility-related fertilization failure. JOURNAL OF CLINICAL MEDICINE. 2020;9(12).
IEEE
[1]
A. Cardona Barberán, A. Boel, F. Vanden Meerschaut, D. Stoop, and B. Heindryckx, “Diagnosis and treatment of male infertility-related fertilization failure,” JOURNAL OF CLINICAL MEDICINE, vol. 9, no. 12, 2020.
@article{8697119,
  abstract     = {{Infertility affects approximately 15% of reproductive-aged couples worldwide, of which up to 30% of the cases are caused by male factors alone. The origin of male infertility is mostly attributed to sperm abnormalities, of which many are caused by genetic defects. The development of intracytoplasmic sperm injection (ICSI) has helped to circumvent most male infertility conditions. However, there is still a challenging group of infertile males whose sperm, although having normal sperm parameters, are unable to activate the oocyte, even after ICSI treatment. While ICSI generally allows fertilization rates of 70 to 80%, total fertilization failure (FF) still occurs in 1 to 3% of ICSI cycles. Phospholipase C zeta (PLC zeta) has been demonstrated to be a critical sperm oocyte activating factor (SOAF) and the absence, reduced, or altered forms of PLC zeta have been shown to cause male infertility-related FF. The purpose of this review is to (i) summarize the current knowledge on PLC zeta as the critical sperm factor for successful fertilization, as well as to discuss the existence of alternative sperm-induced oocyte activation mechanisms, (ii) describe the diagnostic tests available to determine the cause of FF, and (iii) summarize the beneficial effect of assisted oocyte activation (AOA) to overcome FF.}},
  articleno    = {{3899}},
  author       = {{Cardona Barberán, Arantxa and Boel, Annekatrien and Vanden Meerschaut, Frauke and Stoop, Dominic and Heindryckx, Björn}},
  issn         = {{2077-0383}},
  journal      = {{JOURNAL OF CLINICAL MEDICINE}},
  keywords     = {{male infertility,fertilization failure,ICSI,oocyte activation deficiencies,phospholipase C zeta (PLC&#950,),PLCZ1 mutations,MOAT,MOCA,HOCA,AOA,PHOSPHOLIPASE-C-ZETA,INTRACYTOPLASMIC SPERM INJECTION,ASSISTED OOCYTE ACTIVATION,DOMAIN-BINDING-PROTEIN,INDUCED CA2+ OSCILLATIONS,PLC-ZETA,ARTIFICIAL OOCYTE,CALCIUM-IONOPHORE,EGG-ACTIVATION,MOUSE EGGS}},
  language     = {{eng}},
  number       = {{12}},
  pages        = {{31}},
  title        = {{Diagnosis and treatment of male infertility-related fertilization failure}},
  url          = {{http://dx.doi.org/10.3390/jcm9123899}},
  volume       = {{9}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: